Effect of theaflavin-3,3′-digallate on leptin-deficient induced nonalcoholic fatty liver disease might be related to lipid metabolism regulated by the Fads1/PPARδ/Fabp4 axis and gut microbiota

Overview of attention for article published in Frontiers in Pharmacology, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 12 publications that cite this research output.

12

The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.

The mechanistic study of diacylglycerol in ameliorating non-alcoholic fatty liver and systemic lipid accumulation

Article in Journal of Functional Foods (October 2024)

Theaflavins mitigate diabetic symptoms in GK rats by modulating the INSR/PI3K-Akt/GSK-3 pathway and intestinal microbiota

Article in International Journal of Biological Macromolecules (July 2024)

Improvement of Theaflavins on Glucose and Lipid Metabolism in Diabetes Mellitus

Article in Foods (June 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.